John Bardis, chairman, president and CEO of MedAssets, recently summed up the landscape his company and other GPOs are seeing.
“Everyone that we deal with at the hospital level today is focused on cost reduction and clinical integration and managing patients to outcomes with a bent toward resource reduction,” Bardis, who ranks No. 65 in his third appearance on the list, said in a Modern Healthcare interview earlier this month.
Alex Gorsky makes his second appearance on the list at No. 46 since he who took over as chairman and CEO of supply giant Johnson & Johnson last year, a company where he started as a sales rep in 1988.
During a company “business review” in New York this past January, Gorsky laid out his vision for J&J.
“We don't need just new medicines and new products, but we need new philosophies, new approaches, and frankly, a new mindset,” Gorsky said. “We simply have got to reinvent the way we think about healthcare.”
Gorsky noted how people were living longer with conditions such as cancer, mental health disorders and diabetes, and he said J&J was adjusting to this new reality. “We've aligned our businesses, our scientists to focus on meeting the needs of these patients and markets,” Gorsky said.
Meanwhile, McKesson Corp. made news in June when the San Francisco-based drug distributor and health IT company disclosed that Chairman, President and CEO John Hammergren
would have been entitled to receive what was reported to be a record-high corporate pension had he retired in March.
According to U.S. Securities and Exchange Commission filings, Hammergren, who is making his ninth appearance on the list at No. 24, was entitled to receive a one-time payout of $159 million.
Shareholders have protested, though the 54-year-old Hammergren is still on the job.